Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

[The process of meaning-making in adjustment to multiple sclerosis.]
The Bioenergetic Health Index: a new concept in mitochondrial translational research.
Downregulation of cystathionine β-synthase/hydrogen sulfide contributes to rotenone-induced microglia polarization toward M1 type.
Scope and Applications of Nanomedicines for the Management of Multiple Sclerosis.
Pediatric Urinary Retention in the Emergency Department: A Concerning Symptom with Etiology Outside the Bladder.
MMP-9 in Translation: From Molecule to Brain Physiology, Pathology and Therapy.
A machine learning pipeline for multiple sclerosis course detection from clinical scales and patient reported outcomes.
Natalizumab treatment for multiple sclerosis inducing a toxic acute myocardial damage. Is there any relationship?
Liver X Receptors differentially modulate central myelin gene mRNA levels in a region-, age- and isoform-specific manner.
Therapeutic potential of a novel cannabinoid agent CB52 in the mouse model of experimental autoimmune encephalomyelitis.
Management of bladder dysfunction in patients with multiple sclerosis.
Isolated Brain Stem Lesion in Children: Is It Acute Disseminated Encephalomyelitis or Not?
Study protocol: To investigate effects of highly specialized rehabilitation for patients with multiple sclerosis a randomized controlled trial of a personalized, multidisciplinary intervention.
Long-term treatment risks in multiple sclerosis: risk knowledge and risk perception in a large cohort of mitoxantrone-treated patients.
A wireless body measurement system to study fatigue in multiple sclerosis.
Possible induction of acute disseminated encephalomyelitis (ADEM)-like demyelinating illness by intrathecal mesenchymal stem cell injection.
The co-occurrence of pain and depression in adults with multiple sclerosis.
Optimization of sphingosine-1-phosphate-1 receptor agonists: effects of acidic, basic and zwitterionic chemotypes on pharmacokinetic and pharmacodynamic profiles.
Assessment of immune functions and MRI disease activity in relapsing-remitting multiple sclerosis patients switching from natalizumab to fingolimod (ToFingo-Successor).
First-dose effects of fingolimod after switching from injectable therapies in the randomized, open-label, multicenter, Evaluate Patient OutComes (EPOC) study in relapsing multiple sclerosis.
Supporting work for people with multiple sclerosis.
The new therapeutic landscape in multiple sclerosis: exciting times and new perspectives.
Multiple sclerosis registries in Europe - results of a systematic survey.
Correction to: Multiple sclerosis in the Levant: a regional consensus statement.
Cell-Based Modulation of Autoimmune Responses in Multiple Sclerosis and Experimental Autoimmmune Encephalomyelitis: Therapeutic Implications.

Pages